Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000143

Chief Scientific Officer sold 3,892 shares at $4.39 ($17,086)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kishimoto Takashi Kei Chief Scientific Officer 2021-10-13 Sale −3,892 $4.39 $17,086 190,389 D: show line 1 in the form
Open-market sales · 3,892 sh · avg $4.39 · $17,086
Loading xslF345X03/wf-form4_163433564708644.xml…